BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34893062)

  • 1. Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial.
    Kim J; Kim MS; Suh BK; Ko CW; Lee KH; Yoo HW; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Jin DK
    BMC Endocr Disord; 2021 Dec; 21(1):243. PubMed ID: 34893062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
    J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
    Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial.
    Kim SJ; Kim MS; Cho SY; Suh BK; Ko CW; Lee KH; Yoo HW; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Jin DK
    Medicine (Baltimore); 2021 Jul; 100(30):e26711. PubMed ID: 34397702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Committee for the Treatment of Turner Syndrome.
    Takano K; Shizume K; Hibi I; Ogawa M; Okada Y; Suwa S; Tanaka T; Hizuka N
    Horm Res; 1995; 43(4):141-3. PubMed ID: 7750916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome.
    Gao X; Chen J; Cao B; Dou X; Peng Y; Su C; Qin M; Wei L; Fan L; Zhang B; Gong C
    Horm Metab Res; 2022 Jun; 54(6):389-395. PubMed ID: 35504300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome.
    Linglart A; Cabrol S; Berlier P; Stuckens C; Wagner K; de Kerdanet M; Limoni C; Carel JC; Chaussain JL;
    Eur J Endocrinol; 2011 Jun; 164(6):891-7. PubMed ID: 21398400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study of the effectiveness and safety of growth hormone (Humatrope(®)) treatment in Japanese children with growth hormone deficiency or Turner syndrome.
    Tai S; Tanaka T; Hasegawa T; Ozono K; Tanaka H; Kanzaki S; Yokoya S; Fujieda K; Chihara K; Seino Y
    Endocr J; 2013; 60(1):57-64. PubMed ID: 23001148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A; Hagen CP; Nedaeifard L; Juul A; Jensen RB
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32421787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone therapy on adult height of children with Turner syndrome.
    Hsu PY; Tung YC; Tsai WY; Lee JS; Hsiao PH
    J Formos Med Assoc; 2008 Sep; 107(9):704-9. PubMed ID: 18796360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.